Literature DB >> 10841966

Right ventricular long axis function in adults and children with Ebstein's malformation.

J Therrien1, M Y Henein, W Li, J Somerville, M Rigby.   

Abstract

OBJECTIVES: To assess right ventricular function in adults and children with Ebstein's anomaly.
DESIGN: Prospective study.
SETTING: Tertiary referral centre.
SUBJECTS: Fifteen patients (8 adults and 7 children) with Ebstein's anomaly and 14 healthy controls.
INTERVENTIONS: Transthoracic echocardiography was performed in all. Right ventricular function was assessed from long axis M-mode recordings of the right atrio-ventricular free wall. Total systolic excursion as well as peak shortening and lenghtening rates of the right ventricle were measured.
RESULTS: Children and adult patients with Ebstein's anomaly differed in terms of age at diagnosis, the adult group having been diagnosed later 19.8+/-15.8 vs. 5.9+/-6.2 years, P<0.05. Measures of right ventricular long axis function in children with Ebstein's anomaly showed a significantly reduced systolic excursion 1.4+/-0.4 vs. 2.4+/-0.53 cm, P<0.05 and peak lenghtening rate; early 8.04+/-4.3 vs. 11.8+/-2.4 cm/s and late 6.14+/-3.6 vs. 10.6+/-4.3 cm/s, P=0.05 compared to controls. In contrast, measurements of right ventricular long axis function in adults with Ebstein's anomaly showed no significant difference when compared to the control group. Transtricuspid Doppler flow velocities were not different between patient's groups and corresponding controls.
CONCLUSION: The right ventricle assessed by this simple, non-invasive technique reveals a significantly reduced systolic and diastolic function in children with Ebstein's malformation compared to controls but a 'normal' right ventricular function comparable to controls in adult patients. Significant right ventricular dysfunction in children with Ebstein's anomaly could account for their earlier presentation. Long term follow up of the right ventricular abnormalities is needed in such children to discover more about the natural history of the disease.

Entities:  

Mesh:

Year:  2000        PMID: 10841966     DOI: 10.1016/s0167-5273(00)00230-8

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  6 in total

1.  Three-dimensional assessment of two-dimensional technique for evaluation of right ventricular function by tricuspid annulus motion.

Authors:  Jordan L Smith; Edward L Bolson; Selwyn P Wong; Michal Hubka; Florence H Sheehan
Journal:  Int J Cardiovasc Imaging       Date:  2003-06       Impact factor: 2.357

2.  Correlation of right ventricular ejection fraction and tricuspid annular plane systolic excursion in tetralogy of Fallot by magnetic resonance imaging.

Authors:  Peter Morcos; G Wesley Vick; David J Sahn; Michael Jerosch-Herold; Alan Shurman; Florence H Sheehan
Journal:  Int J Cardiovasc Imaging       Date:  2008-12-02       Impact factor: 2.357

3.  Incidental Finding of Ebstein's Anomaly in an Adolescent with an Upper Respiratory Infection: A Case Report.

Authors:  Rohit Kapoor; Premila Paul; Premchand Anne
Journal:  J Clin Diagn Res       Date:  2016-03-01

4.  Diagnosis and management of ebstein anomaly of the tricuspid valve.

Authors:  Eric V Krieger; Anne Marie Valente
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-12

5.  Quantification of biventricular myocardial function using cardiac magnetic resonance feature tracking, endocardial border delineation and echocardiographic speckle tracking in patients with repaired tetralogy of Fallot and healthy controls.

Authors:  Aleksander Kempny; Rodrigo Fernández-Jiménez; Stefan Orwat; Pia Schuler; Alexander C Bunck; David Maintz; Helmut Baumgartner; Gerhard-Paul Diller
Journal:  J Cardiovasc Magn Reson       Date:  2012-05-31       Impact factor: 5.364

6.  Value of assessment of tricuspid annulus: real-time three-dimensional echocardiography and magnetic resonance imaging.

Authors:  Ashraf M Anwar; Osama I I Soliman; Attila Nemes; Robert-Jan M van Geuns; Marcel L Geleijnse; Folkert J Ten Cate
Journal:  Int J Cardiovasc Imaging       Date:  2007-02-13       Impact factor: 2.357

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.